{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:13:20Z","timestamp":1794377600576,"version":"4.9.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004097","name":"ARC Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.xcrm.2024.101549","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T10:36:32Z","timestamp":1714732592000},"page":"101549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip"],"prefix":"10.1016","volume":"5","author":[{"given":"Irina","family":"Veith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Nurmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Mencattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Damei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lansche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solenn","family":"Brosseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Gropplero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Corgnac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pot\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Guenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Chassac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Mordant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimena","family":"Tosello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sedlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Piaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Camonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamasseh","family":"Shirvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathia","family":"Mami-Chouaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Mechta-Grigoriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Descroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Zalcman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7082-9792","authenticated-orcid":false,"given":"Maria Carla","family":"Parrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101549_bib1","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2024.101549_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2014.07.002","article-title":"Microfluidic 3D models of cancer","volume":"79\u201380","author":"Sung","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2024.101549_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trecan.2015.12.003","article-title":"Microfluidics: A new tool for modeling cancer-immune interactions","volume":"2","author":"Boussommier-Calleja","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2024.101549_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","article-title":"Modelling cancer in microfluidic human organs-on-chips","volume":"19","author":"Sontheimer-Phelps","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2024.101549_bib5","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1039\/D3LC00531C","article-title":"Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies","volume":"23","author":"Bouquerel","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.xcrm.2024.101549_bib6","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1016\/j.celrep.2018.12.015","article-title":"Dissecting Effects of Anti-cancer Drugs and Cancer-Associated Fibroblasts by On-Chip Reconstitution of Immunocompetent Tumor Microenvironments","volume":"25","author":"Nguyen","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101549_bib7","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/s41467-022-30575-2","article-title":"High resolution microfluidic assay and probabilistic modeling reveal cooperation between T\u00a0cells in tumor killing","volume":"13","author":"Ronteix","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101549_bib8","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101549_bib9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.19.03136","article-title":"Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer","volume":"38","author":"Gadgeel","year":"2020","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101549_bib10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41417-020-0174-y","article-title":"TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials","volume":"27","author":"Choucair","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101549_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.semcancer.2018.05.006","article-title":"Emerging biomarkers for immune checkpoint inhibition in lung cancer","volume":"52","author":"Cyriac","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.xcrm.2024.101549_bib12","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.21037\/tlcr-20-941","article-title":"Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis","volume":"10","author":"Guaitoli","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101549_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101549_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41571-019-0173-9","article-title":"Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC","volume":"16","author":"Camidge","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101549_bib15","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101549_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101549_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/intimm\/12.4.537","article-title":"Evidence for in\u00a0situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung","volume":"12","author":"Echchakir","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.xcrm.2024.101549_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1097-0142(20010101)91:1<113::AID-CNCR15>3.0.CO;2-7","volume":"91","author":"Asselin-Paturel","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2024.101549_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008870","article-title":"Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death","volume":"17","author":"Veith","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.xcrm.2024.101549_bib20","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1038\/s41598-019-42475-5","article-title":"The influence of spatial and temporal resolutions on the analysis of cell-cell interaction: a systematic study for time-lapse microscopy applications","volume":"9","author":"Comes","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101549_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114571","article-title":"Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus","volume":"215","author":"Mencattini","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.xcrm.2024.101549_bib22","doi-asserted-by":"crossref","first-page":"13515","DOI":"10.1073\/pnas.1210182109","article-title":"Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function","volume":"109","author":"Zervantonakis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101549_bib23","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1039\/C8LC00322J","article-title":"3D microfluidic ex\u00a0vivo culture of organotypic tumor spheroids to model immune checkpoint blockade","volume":"18","author":"Aref","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.xcrm.2024.101549_bib24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fimmu.2018.00416","article-title":"Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101549_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89762","article-title":"A 3D microfluidic model for preclinical evaluation of TCR-engineered T\u00a0cells against solid tumors","volume":"2","author":"Pavesi","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2024.101549_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89014","article-title":"Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes","volume":"1","author":"Lizotte","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2024.101549_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaoncol.2022.4933","article-title":"Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC","volume":"9","author":"Rakaee","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xcrm.2024.101549_bib28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4049\/jimmunol.169.2.809","article-title":"Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)\/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L\/TRAIL expression and -mediated cytotoxicity","volume":"169","author":"Doroth\u00e9e","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2024.101549_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101549_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41467-019-14134-w","article-title":"Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms","volume":"11","author":"Pelon","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101549_bib31","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41467-018-03348-z","article-title":"miR200-regulated CXCL12\u03b2 promotes fibroblast heterogeneity and immunosuppression in ovarian cancers","volume":"9","author":"Givel","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101549_bib32","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41467-024-45595-3","article-title":"Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway","volume":"15","author":"Licaj","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101549_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100267","article-title":"Isolation of tumor-resident CD8+ T\u00a0cells from human lung tumors","volume":"2","author":"Corgnac","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2024.101549_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0000000000000147","article-title":"The Characteristics of Naive-like T Cells in Tumor-infiltrating Lymphocytes From Human Lung Cancer","volume":"40","author":"Sheng","year":"2017","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.xcrm.2024.101549_bib35","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.4049\/jimmunol.1402711","article-title":"CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T\u00a0cells and a prognostic factor for survival in lung cancer patients","volume":"194","author":"Djenidi","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2024.101549_bib36","article-title":"CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17","volume":"1","author":"Corgnac","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2024.101549_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"10.1016\/j.xcrm.2024.101549_bib38","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1158\/1078-0432.CCR-0994-03","article-title":"Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study","volume":"10","author":"Fouquet","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101549_bib39","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(16)00004-0","article-title":"Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)","volume":"387","author":"Barlesi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101549_bib40","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101549_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101549_bib42","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101549_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107588","article-title":"Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine","volume":"31","author":"Dijkstra","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101549_bib44","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41591-021-01398-3","article-title":"An ex\u00a0vivo tumor fragment platform to dissect response to PD-1 blockade in cancer","volume":"27","author":"Voabil","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101549_bib45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","article-title":"Ex\u00a0Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids","volume":"8","author":"Jenkins","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101549_bib46","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1038\/s41598-020-64246-3","article-title":"Discovering the hidden messages within cell trajectories using a deep learning approach for in\u00a0vitro evaluation of cancer drug treatments","volume":"10","author":"Mencattini","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101549_bib47","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1039\/D2LC00696K","article-title":"Precise and fast control of the dissolved oxygen level for tumor-on-chip","volume":"22","author":"Bouquerel","year":"2022","journal-title":"Lab Chip"},{"key":"10.1016\/j.xcrm.2024.101549_bib48","doi-asserted-by":"crossref","first-page":"12139","DOI":"10.1073\/pnas.1412910111","article-title":"Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T\u00a0cells","volume":"111","author":"Denton","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101549_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11762","article-title":"Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis","volume":"7","author":"Ruhland","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101549_bib50","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101549_bib51","doi-asserted-by":"crossref","first-page":"23282","DOI":"10.18632\/oncotarget.7818","article-title":"Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2024.101549_bib52","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101549_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-024-04949-7","article-title":"YAP\/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancer","author":"Brosseau","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.xcrm.2024.101549_bib54","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.7150\/thno.71761","article-title":"Evaluation of cancer immunotherapy using mini-tumor chips","volume":"12","author":"Ao","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2024.101549_bib58","doi-asserted-by":"crossref","first-page":"12737","DOI":"10.1038\/s41598-017-13070-3","article-title":"Organs on chip approach: a tool to evaluate cancer-immune cells interactions","volume":"7","author":"Biselli","year":"2017","journal-title":"Scientific reports"},{"key":"10.1016\/j.xcrm.2024.101549_bib59","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41598-017-01013-x","article-title":"3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells","volume":"7","author":"Parlato","year":"2017","journal-title":"Scientific reports"},{"key":"10.1016\/j.xcrm.2024.101549_bib55","series-title":"Machine Vision: Theory, Algorithms, Practicalities","author":"Davies","year":"2005"},{"key":"10.1016\/j.xcrm.2024.101549_bib56","article-title":"Digital image processing","volume":"19","author":"Gonzalez","year":"2018"},{"key":"10.1016\/j.xcrm.2024.101549_bib57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01404567","article-title":"Smoothing noisy data with spline functions","volume":"31","author":"Craven","year":"1978","journal-title":"Numer. Math."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124002416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124002416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T15:17:00Z","timestamp":1733757420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124002416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2666379124002416"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101549","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101549"}}